Skip to main content
. 2017 Sep 23;8(49):86488–86502. doi: 10.18632/oncotarget.21212

Figure 5. Effect of PSC-derived Galectin-1 on EMT of cancer cells in vivo.

Figure 5

Immunohistochemistry staining for Galectin-1 (A–C), E-cadherin (D–F), and Vimentin (G–I) expression in orthotopic xenograft tissues. Original magnification: ×200. (J) The mean density of Galectin-1 in the different orthotopic xenograft tissues. (K) The mean density of E-cadherin and Vimentin in the different orthotopic xenograft tissues. Original magnification: 200×. *p < 0.05, **p < 0.01, #p > 0.05 vs. wt-Galectin-1 PSCs.